Comprehensive Study of Human FBXW7 Deleterious nsSNP's Functional Inference and Susceptibility to Gynaecological Cancer

<jats:title>Abstract</jats:title>         <jats:p>Cancer is one of the world's major causes of mortality, and it plays a most important role in the world's declining life expectancy. F-box and WD-40 domain protein 7 (FBXW7), a typical participant of the F-box family of proteins, has been considered as an antitumor protein and one of the maximum deregulated ubiquitin-proteasome system proteins in uterine carcinosarcoma, endometrial clear cell carcinoma and cervical carcinoma with the greatest prevalence of alterations. FBXW7 variants with known clinical significance, as well as nsSNP’s in the F-Box and WD40 domains, were evaluated using functionality prediction web resources. Upon analysing the seventy-three deleterious nsSNP’s impact on protein stability and function, we identified that forty-one nsSNP’s of WD40 domain and three of F-Box domain imply decreased stability of the FBXW7 structure. Next to TP53 and PTEN, FBXW7 was reported with the highest percentage of arginine substitution among mutations related to cancer. The current research concentrated on two arginine residue locations (Arg465, Arg505) within the WD40-repeat domain, which is vital for substrate binding. Computational analysis revealed that significant deviation in stability and structural configuration of mutants R505L, R465H, R465P, R505G, R505C, R465C R505S and R505L structures. Protein–protein interaction network of FBXW7 populated with promising hub proteins NOTCH1, c-Myc, CCNE1, STYX, KLG5, SREB1, NFKB2, SKP1, CUL1, thus alteration in the FBXW7 leads to aberration in their signalling pathways as well as their substrate binding ability makes this protein as attractive target for personalized therapeutic intervention.</jats:p>

section_content: Cancer is one of the prominent reasons for mortality globally, including increased life expectancy. GLOBACAN 2020, a Global Cancer Observatory statistics statement, publicised that breast cancer and cervical cancer are more predominant amongst the Indian population [1]. The disruption of various essential biochemical pathways and biological processes, including ubiquitination, is known to cause cancer. Proteasomal breakdown mediated via the ubiquitin-proteasome system (UPS) is the predominant eukaryotic proteolytic activity for more than 80% of proteins that control the cell cycle, cell proliferation, and death [2]. Therefore, the aberration of the UPS paves the way for cancer induction. Ubiquitination occurs when the ubiquitin protein binds to the target protein, causing enzymes like ubiquitin-activating enzyme (E1), ubiquitin-conjugating enzyme (E2), and ubiquitin ligase to act (E3). A ubiquitin ligase (E3) attaches to substrate proteins and then causes them to be degraded by another enzyme called the 26S proteasome. Variation in ubiquitin ligase E3 function has been discovered to be one of the important contributors in the initiation and progression of cancer, according to research [3]. Among the various forms of E3 ubiquitin ligases, the SCF (Skp1-Cullin1-F-box) complex, which comprised of the scaffold protein Cullin1 (Cul1), the RING nger protein Rbx1, the linker protein S phase kinase-associated protein 1 (Skp1), and the F-box protein, has been extensively studied [4]. In humans, there are 69 F-box proteins, each of which has an F-box motif in its amino-terminal region and a carboxyl terminal containing WD-tryptophan and aspartic acid or leucinerich repeats. -LRR [5]. Thus, the F-box is categorized as FBXW-F-box combined with WD repeats, FBXO-F-box with no motifs, FBXL-F-box coupled with LRR. F-box with 7 tandem WD40 repeats (FBXW7), which is known for its oncogenic substrates' recognition and targeting to facilitate ubiquitin-mediated degradation in many human malignancies. Furthermore, recent research has revealed their in uence on chemotherapy resistance [6]. 

Phosphorylation of the conserved FBXW7 phosphodegron motifs on the substrates is essential for FBXW7 to bind with and target them for destruction. FBXW7 is known for its participation in the oncoprotein targets cyclin E, c-JUN, c-MYC, NOTCH-1, and MCL-1 in ubiquitylation and proteasome destruction. Knock out research ndings revealed that almost ninety proteins were targeted as substrates by FBXW7. FBXW7 targets are mostly transcription factors or important signalling molecules that control a variety of cellular activities, such as primary proliferation and tumour growth. FBXW7 mutations owing to chromosomal deletion or mutation, as well as promoter hypermethylation, are common in a variety of human malignancies [7]. In at least 16 percent of human endometrial tumours, FBXW7 has been found to be mutated. These mutations were found in the protein's aminoterminal region or the substrate-binding domain [8]. Though the most prevalent endometrial cancer (EC) histotype, endometrioid EC, can often be cured with hysterectomy, serous EC is an uncommon category that is coupled with metastases, relapse, therapy sensitivity, and poor prognosis [9]. The tumour suppressor FBXW7 is typically mutated in serous ECs compared with other clinically aggressive subtypes [8, 12]. Nearly 15%-29% of serous ECs, 11-39% of uterine carcinosarcomas, 13-25% of clear cell endometrial cancers, and 0%-15% of endometrioid endometrial cancers were reported with somatic mutations in FBXW7 [10, 11]. As a result, it has been hypothesized that reduced expression or deletion of FBXW7 in breast cancer leads to an accumulation of oncogenic transcription factors, which are key regulators of proliferation, apoptosis, and eventually transformation [13]. 

Mutations not only assist the oncogenic substrate accumulation but also direct the resistance phenotype of T-ALL cell lines in response to a gamma-secretase inhibitor [14]. These data show that FBXW7 could be exploited as a potential target for overcoming chemo resistance in a variety of cancers, not merely as a biomarker for predicting chemotherapy effectiveness. As a result, we evaluated sequence and structure-based bioinformatics protein stability indicator techniques to anticipate the effect of the mutation on FBXW7 protein stability to get extensive structural and mechanistic insight of wild type to mutant FBXW7 protein structures. The results of these computational investigations suggest that structural changes caused by missense mutations may affect FBXW7's functional activity, which will aid in the development of inhibitors.
section_name: Introduction

section_name: Materials And Methods

section_content: The expression of FBXW7 in different cancers was higher when compared with 21 other cancer types in the TCGA database. Acute myeloid leukaemia had the lowest mRNA expression of FBXW7. FBXW7 expression in OSC was the highest among the 21 types of cancers documented in the TCGA. Data on FBXW7 mutational frequency was gathered from databases such as the Single Nucleotide Polymorphism database [15] and the Catalogue of Somatic Mutations in Cancer (COSMIC), which, based on the reference database GRCh37/hg19, includes both healthy (controls) and disease populations with gynaecological cancers. In addition, we utilized the CLINVar database to screen the listed mutants and their clinical signi cance among gynaecological cancer patients [16].
section_name: TCGA based expression analysis and mutant screening of FBXW7 gene

section_content: Through functional study of protein families, InterPro, a domain screening tool, calculates a protein's domains and active sites. It projected three FBXW7 functional domains: FBOX domain (278-235), WD40-Repeat-containing domain (376-659), and FBOX-LIKE domain (282-325) and showed that all ten clinically signi cant nsSNPs were in the WD40-Repeat-containing domain [17]. nsSNP's localized in both F box and WD40 domain were considered for further study.
section_name: Screening of nsSNPs prevalence in FBXW7 functional domain

section_content: SIFT, PANTHER, PolyPhen-2 and SNPs & GO, PROVEAN, and PredictSNP were used to assess the functional effects of the variant retrieved from the clinvar database, as well as SNPs located in the F box and WD40 domain. 

This validated the ndings' precision and rigour, and we classi ed those variations as harmful to all six programmes. The SIFT algorithm calculates the impact of amino acid substitutions using sequence homology to uncover both helpful and hazardous variants. Substitution of amino acids in speci c residue positions with a probability of 0. 05 is thought to be deleterious and intolerant, whereas substitution with a probability greater than 0. 05 is thought to be tolerant [18]. The PANTHER programme categorises proteins according to their evolutionary links, molecular activities, and interactions with other proteins. It assesses modi cations using position-speci c evolutionary conservation scores derived from the alignment of multiple evolutionarily related proteins [19]. Based on sequence-based characterisation, PolyPhen-2 predicts the functional impact of amino acid changes on FBXW7 structure and functions [20]. The SNPs & GO server uses support vector machines (SVM) to evaluate human disease-related variants [21]. PROVEAN is a web server that evaluates the functional impact of the listed amino acid changes based on sequence homology. PROVEAN's cut-off value is set to -2. 5. Amino acid substitutions that above the cut-off threshold were considered harmful [22]. PredictSNP, a consensus classi er, predicts and annotates SNPs using the Protein Mutant Database and the UniProt database [23]. 

Analysing the effect of the mutant's impact on FBXW7 structural stability A mutation alters the structure and stability of a protein in general. As a result, we used I-Mutant, a web server that uses a support vector machine to predict the stability of a protein after it has been modi ed. This database makes use of the ProTeam-derived dataset, which is the most comprehensive collection of research data on protein mutations. It computes the Gibbs free energy of native and mutant structures to evaluate free energy transformations. We submitted the clinvar based 10 nsSNPs as well as SNPs localized in the F box and WD40 domain of FBXW7 in FASTA format to assess the mutant's stability [24].
section_name: Screening of deleterious mutant's functional effects in FBXW7

section_content: ConSurf, which uses a Bayesian technique to analyse phylogenetic relationships between homologous sequences, was used to estimate the evolutionary conservation of amino acids in the protein sequence. 

Conservation scores with a colour system were used here to identify conserved areas, which are then assigned to various nine-grade scales. Variable conservation scores range from 1 to 4, intermediate conservation scores range from 5 to 6, and conserved conservation scores range from 7 to 9. For further analysis, we looked at the FBXW7 mutant's distribution and their score for further analysis [25]. 

Structure analysis of wild type and mutant models. 

The 3D structure of native FBXW7 (2OVP) was retrieved from the Protein Data Bank [26]. The deleterious mutants were discretely substituted into the native sequence and 3D models for all the FBXW7 mutants were generated. 

The molecular con guration and its exibility represent the main key properties of a protein molecule's biological function. To circumvent the practical di culties surrounding laboratory techniques, we decided to generate the conformation exibility of the wild and mutant FBXW7 protein using the CABS-ex web server. This server analysed the near native dynamics of globular proteins using a coarse-grain protein modelling approach to generate complete knowledge about the protein structure, conformational alterations, and residue level uctuations. Structural comparisons between native and mutant models were explored based on an RMSF graph using CABS ex 2. 0 [27]. FBXW7-WD40 repeat containing domain location mutant models and wild protein structures were generated using swisspdb-viewer and RMSD was predicted by PYMOL [28]. 

Prediction of structural effect of nsSNPs on human FBXW7 protein We enlisted the help of HOPE to gure out how mutations affect protein structure. Project Have yOur Protein Explained (HOPE) is a web server that determines how point mutations in a protein sequence affect its structure [29]. Project HOPE predicted the hydrophobicity, charge, and size change between wild-type and mutant residue and the mutant model of the FBXW7 3D structure. Besides, we also employed Missense 3D [30] to con rm the precision and rigor of our result. The structural changes caused by an amino acid substitution are depicted in Model 3D. 

Assessing the protein-protein interaction network of FBXW7 Asserting the connections between proteins is vital to maintaining the homeostasis of the living system. The reactome database-based molecular interaction networks of the human FBXW7 protein with other linked proteins were visualised using Cytoscape, a free Java-based software application [31]. The Cytoscape GUI platform was used to visualise interacting networks of various types of protein [32].
section_name: Analysing protein evolutionary conservation

section_content: For most of the pathogenic variants, a strongly destabilizing mutation corresponds to the loss of function, whereas a modest change in stability may generate changes in protein conformation affecting the binding a nity with interacting molecules (protein, RNA and DNA). The in uence of amino acid modi cations on protein stability, on the other hand, is critical information for precision medicine [33].
section_name: Results & Discussion

section_content: To have an overview of FBXw7 expression in different solid tumours, we analysed its expression in samples from the TCGA, which revealed that FBXw7 is coupled with differential expression as well as cervical, endometrial, and ovarian cancer in women (Fig. 1 ).
section_name: TCGA based expression analysis and alterations in the FBXW7 gene

section_content: We used the NCBI dbSNP database to evaluate reported FBXW7 variants, which include SNPs in the intronic region, 49,125 SNPs, and 701 SNPs in the non-coding area. Within the coding sequence, there were nearly 394 missense (nsSNPs) and 257 synonymous SNPs. The current study included clinically signi cant nsSNPs and mutants to investigate their impact on the FBXW7 structure. In addition to that, uncharacterized nsSNPs were assessed for their structural and functional level impact (Table. 1). In addition to that, 57 nSSNP's located in the Fbox and WD40 domain were also included in the current study.
section_name: Retrieving nsSNPs.

section_content: SIFT, PANTHER, PolyPhen-2, SNPs & GO, PROVEAN, and PredictSNP were used to screen the mutant's impact at the sequencing and structural levels. As per prediction, ten proposed variants with clinical signi cance are considered as deleterious variants in all computational prediction methods (Table. 2). The F-box and WD40 domain variants' impacts were also predicted and tabulated. 

Screening of mutant residues prevalence within FBXW7 domains InterPro, a domain identi cation tool, uses the protein family's functional analysis concept to predict a protein's domains as well as its active sites. To assess the position of variants within the conserved domains of FBXW7, we used the InterPro tool, which can identify motifs and domains of a protein. It is projected that two functional domains of FBXW7, which are 1PR001810 indicate F-BOX domain (278-325), and IPR17986 indicates WD40repeat-containing domain (376-659) and FBXW7 variants of current study were positioned on second domain (Fig. 2 ). Within the propeller phosphorylation-binding region, three arginine Missense point mutant residues (R465, R479, and R505) prohibit Fbxw7 from binding substrate [33]. The F-box domain contains nsSNPs and a few premature truncation cause variants. So far, nearly twenty-one premature truncation variants have been reported in the WD40 domain. Sixty-eight nsSNPs were reported in the WD40 domain, ve nsSNP's in the F-Box domain, thus their deleterious effect was assessed using consensus prediction results. (Supplementary table. 1)

Exploring the impact of the nsSNPs on protein stability I-Mutant is a tool that assesses the in uence of mutations on protein stability using a neural network technique. I-Mutant calculates the degree of protein instability and displays the projected free energy change value (G) as well as the prediction's sign: decrease or increase. The ΔΔG value predicted by I-Mutant revealed that all Clinvar proposed variants decreased stability (Table. 3). In addition, we examined all the nsSNPs found in both domains of FBXW7. The support vector machine-based algorithm used here effectively predicted the transformation in protein stability free energy of the proposed FBXW7 mutants. The elevated negative DDG score suggests it is highly deleterious. (Supplementary table. 2)
section_name: Detection of harmful substances SNPs

section_content: The ConSurf web server revealed the evolutionary conservation of amino acid residues in native FBXW7. We looked at the evolutionary conservation and solvent accessibility of the FBXW7 mutant's structural and functional residues. R465 and R505 were found to be exposed and functional, whereas both mutants' residues were buried and structural. All these mutant residues have a high level of conservation (Table. 4). Furthermore, both residues are expected to be relatively conserved and exposed, whereas both mutants are anticipated to be conserved and buried (Fig. 3 ). 

Structural changes are re ected through the energy state of the FBXW7 mutant models in the SwissPDB viewer assessment. Mutant models were visualized using Pymol and RMSD values were tabulated (Table. 5 ). The potential energy of the wild type FBXW7 structure was observed at -11346. 87 kJ/mol following energy minimization. Similarly, other mutants showed that R465H (-17. 713 kJ/mol), which considerably diminished total energy, but R465P (-17. 161 kJ/ mol) (Fig. 5 ), R465L (-16,953kJ/mol), and R505H (-16. 667 kJ/mol) were the top three mutants that impacted the FBXW7 structure by increasing the total energy after energy minimization (Table. 6).
section_name: Evolutionary conservation analysis

section_content: The Project HOPE server revealed that substituting Glycine in R505G, R465G can cause FBXW7 protein stiffness to be disrupted. Furthermore, R505L, R465H, R465L and R465P can be mutations located within a speci cation that is frequent in the protein repeat and is known as WD3. The mutation into a new residue might interrupt this repeat and, consequently, their substrate binding capability (Fig. 4 ). Interference with both salt bridge and hydrogen bonding was seen in R505C mutants. The ability of a protein structure to offer speci c activities depends on its exibility and rigidity nature. Besides this, the R505H and R505S mutants expose distinct properties and so they might drastically alter the functional FBXW7 associating domain (Table. 7 ). Missense 3D tool stated that R465L, R465C, R465G, R465H, R465P, R505L, R505C variant created a buried Proline that delivers constrained backbone conformation. Moreover, R465L, R465C, R465G, R465H, R465P, R505L, R505C interrupted the sidechain and main-chain H-bond (s) established by wild type buried Arginine residue and R505L, R505G and R505S substitution triggered the expansion of cavity size (Table. 8). The R505C substitution caused a shift from buried to exposed states, with the ARG exposed (RSA 23. 7%) and the introduced mutant CYS buried (RSA 5. 1%). Similarly, in R505L, ARG is exposed (RSA 23. 7%) and LEU is buried (RSA 6. 7%). The R465P substitution converts the 'E' (extended strand in parallel and/or anti-parallel -sheet conformation) to the '' (no secondary structure). nsSNPs found in both domains of FBXW7 were also evaluated for structural level changes and are included in the supplementary le. 1 FBXW7 mutants' structural level impact on its molecular interactors Cytoscape was employed to construct the protein interaction network of FBXW7 protein, and it projected that the F-box family of proteins is functionally linked with 311 proteins, among which the top ten hub proteins NOTCH1, c-Myc, CCNE1, STYX, KLF5, SREB1, NFKB2, SKP1, CUL1 were included for the current study to explore the FBXW7 structural variants impact protein protein interaction (Table. 9). The Cytoscape based protein-protein interaction network was based on the graph theory parameters, namely degree, average shortest path length, betweenness centrality, closeness centrality, and neighbourhood connectivity (Fig. 5 ). 

F-box protein Fbw7 (gene FBXW7), which forms the E3 ubiquitin ligase complex SCFFbw7 with Skp1 and Cullin1 [34]. Uterine carcinosarcoma (UCS) is a biphasic, high-grade endometrial cancer with de-differentiated sarcoma and carcinoma features. UCS tumours are serous-like, according to next-generation sequencing, and common somatic mutations are found in them. According to next-generation sequencing, UCS tumours are considered as serious-like and observed with somatic mutations in certain genes, namely TP53, PIK3CA, FBXW7, PTEN, and ARID1A [35]. 

Metaplastic breast carcinoma (MBC) and Uterine carcinosarcoma (UCS) anchorage have repeated somatic genetic changes in uencing TP53 and a few other genes associated with the PI3K, Wnt, and Notch pathways. The histologically dissimilar components identi ed in MBCs and UCSs were discovered to be clonally related, and, at least in some cases, their mesenchymal component presumably arose from the epithelial component. Despite this, a few differences, speci cally genetic alterations, distinguish MBCs and UCSs, as well as the role of the corresponding pathway in tumour induction The frequency of FBXW7 and PPP2R1A mutations, HER2 augmentation, and the absence of HRD distinguish UCSs from MBCs [36]. Endometrial carcinoma (EC) is a clinically diverse disease with a wide range of histological subtypes, and this heterogeneity may play a role in the accumulation of genetic alterations in the mutations were linked to late-stage cancer, vascular invasion, and lymph node metastatic disease [37]. Reported studies have revealed that about 15%-29% of serous ECs, 11%-39% of uterine carcinosarcomas, 13%-25% of clear cell endometrial cancers, and 0%-15% of endometrioid endometrial cancers show somatic mutations in FBXW7 [38]. Besides the most common serous ECs, somatic mutational hotspots are listed as 423, 465, 479, and 505 residues [39]. genes FBXW7, PTEN, PIK3CA, TP53, KRAS, CTNNB1, FBFR2, and RB1. FBWX7

The coding region of the FBXW7 gene contains isoform-speci c 5-exons, a nuclear localization signal, an F-box motif, and a WD40 domain. The Phosphorylated substrates such as cyclin E, Notch, cJun, MYC, PS1, and SREBF bind to this functional region. GSK3/FBXW7-dependent degradation of sterol regulatory element-binding protein 1 (SREBP1) suppresses lipogenesis in cancer cells when mTOR complex 2 is inhibited [40]. WD40 repeats, generating a propeller shape that may be observed on the surface or lumen of the h-propeller structure and is embedded with R465, R479, and R505 residues. As a result, such point mutations could impair substrate binding and interfere with wild type FBXW7 activity, implying a central negative effect. The WDR protein FBXW7 has a part in human cancer since it is the prime aberrated protein in the ubiquitin / proteasome system (UPS) seen among cancer patients [41]. The tumour suppressor protein FBXW7 interacts to substrate protein via phosphorylation and initiate breakdown process. FBXW7 gene loss-of-function mutations cause an abnormal build-up of cyclin E, which is found in 18% of colorectal malignancies, 15% of uterine endometrial carcinoma, and 40% of uterine carcinosarcoma [41, 42]. Surprisingly, these changed residues lead to the outside of the WD40-sheet domain, signalling that they are close to FBXW7-interacting substrate proteins. R505H, R505L, R505S, R505G, R505C, R465L, R465P, R465H, R465G, R465C mutations in FBXW7 resulted in changes in hydrophobic behaviour and electrostatic surface interactions, as well as a change in substrate binding. 

FBXW7 mutants increases cancer-originating cell action in association with Notch1 oncogenes. Through skin carcinogenesis, FBXW7 regulates keratinocyte proliferation and differentiation, utilising both repressive and stimulatory signals, primarily through maintaining the proliferation-enhancing drive of c-Myc and the tumorsuppressive action of NOTCH [43]. Inactivation of FBXW7 has been shown to increase tumour resistance to antitubulin chemotherapeutic drugs. Furthermore, in cancer types that enhance resistance to gamma-secretase inhibitors, deletion of FBXW7 has been revealed to be a crucial prognostic marker (GSIs). These promising ndings show that targeting NOTCH and/or FBXW7 to overcome MDR is a viable option. The biological importance of NOTCH and FBXW7 dysregulation in inducing MDR in tumours is discussed in the following sections [44, 45]. Still, deregulation of FBXW7 and NOTCH activity can occur because of circumstances such as a mutation that disrupts the homeostatic state, leading to neoplastic transformation. 

A recent study emphasises the speci c variants, like FBXW7 R505L, localized in WD repeat 4 of the Fbxw7 protein. 

The Exon 9 based variant R465C of FBXW7 was reported numerous times for missense mutation occurrence (18. 6%). Likewise, R465H and R505C were the next most familiar FBXW7 missense mutations (16. 3% each) among the gynaecological conditions. Fbxw7 is rendered inactive by R505L, as evidenced by the activation of the NOTCH pathway in cultured cells [46] and the inability to bind substrates [47]. Another damaging mutation, R505C, is discovered in the WD repeat 4 of the Fbxw7 protein. R505C disrupts FBXW7-substrate interaction and impairs FBXW7 substrate degradation, leading to increased Notch intracellular domain and Myc expression [42], aberrant subnuclear localization [48], and decreased KLF5 degradation [49]. Mutant R465C is found in the Fbxw7 protein's WD repeat 3. In R465C mice, Fbxw7 protein function is lost, as indicated by a lack of Fbxw7-substrate interaction and poor substrate degradation by Fbxw7, resulting in prolonged Notch1 intracellular domain and Myc expression [46], as well as decreased degradation of Klf5 [49]. In culture, aberrant subnuclear localization resulted in lower inhibition of migration, invasion, and colony formation compared to wild-type Fbxw7 [48, 50]. The WD repeat 3 of the Fbxw7 protein contains R465H (which corresponds to R385H in isoform 2. R465H prevents FBXW7 substrate degradation by preventing FBXW7-substrate contact, resulting in extended NICD and MYC expression [46], as well as KLF5 degradation [49]. H468R is in the WD repeat 3 of the Fbxw7 protein. H468R causes the Fbxw7 protein to lose function, as evidenced by the inability to induce the degradation of cyclin E, c-Myc, Mcl-1, and Braf in cultured cells [51], confers resistance to some BET inhibitors in cultured cells [52], and causes impaired NICD degradation in cultured cells, potentially leading to increased Notch1 signalling [53]. R479H is found in the Fbxw7 protein's WD repeat domain. This variation results in FBXW7 substrate degradation and a lack of FBXW7-substrate interaction, resulting in Notch-driven reporter activation [52]. R479Q is present in the WD repeat 3 of the Fbxw7 protein. R479Q prevents FBXW7 from degrading substrates, resulting in prolonged Notch1 intracellular domain and Myc expression [46, 53], as well as aberrant subcellular nuclear localization and loss of Notch1 intracellular domain binding in culture [48]. The FBXW7 R505H mutation is found in Fbxw7's WD repeat 4. R505H has been found in sequencing studies [54, 55, 56], but it has not been biochemically described. Therefore, its impact on the function of the Fbxw7 protein is unknown. R505G is found in the Fbxw7 protein's WD repeat 4. In cell culture studies, variant R505G causes enhanced proliferation, migration, invasion, and colony formation [50], implying that the Fbxw7 protein function will be lost. R465L is found in the Fbxw7 protein's WD repeat domain 3. This variant results in FBXW7 substrate degradation and a lack of FBXW7-substrate interaction, resulting in Notch-driven reporter activation [57]. The WD repeat domain of the Fbxw7 protein contains R465P. Other R465 hotspots inactivate Fbxw7, but R465P has yet to be explored. As a result, R465P is predicted to result in function loss [46, 57, 58 ]. R465Y has not been detected in the WD repeat domain of the Fbxw7 protein, however other R465 hotspots inactivate Fbxw7. As a result, R465Y is likely to cause function loss [46, 57, 58]. The WD repeat domain of the Fbxw7 protein contains R479L. This mutation causes the Fbxw7 protein to lose function, as seen by increased ubiquitination and lower protein stability [59]. R479P is found in the Fbxw7 protein's WD repeat domain. In culture, R479P causes enhanced proliferation, migration, invasion, and colony formation [50], implying that Fbxw7 protein function will be lost. 

NFκB2 precursor protein is recognised as one of the main Fbw7 substrates. We identi ed NFκB2 as a downstream ubiquitin substrate of Fbw7 since it is a physiological interactor of SCFFbw7 [60]. Furthermore, the transcription factor nuclear factor kappa B (NF-kB2) is well-known for controlling cell survival, tumour invasion, and treatment resistance via the regulation of many oncogenic gene products [61]. Tumour suppressor FBXW7 is a component of the SCF (Skp1, Cullin 1, F-box protein) ubiquitin ligase complex, which regulates the degradation of a variety of substrates that, if not correctly regulated, might contribute to carcinogenesis. We show that FBXW7 mutations increase phosphorylated SRC-3, Cyclin E1, and c-MYC levels. Increased amounts of phosphorylated proteins have been linked to recurrent FBXW7 mutations, the majority of which occur in druggable pathways [62]. STYX has been associated to colorectal cancer cell proliferation, migration, invasion, and apoptosis, and several studies have suggested that STYX serves as a latent oncogene that inhibits apoptosis in colorectal and breast cancer, particularly via interacting with the FBXW7 protein. Collectively, these explanations reveal that the STYX/FBXW7 axis is engaged in the promotion of EC cells and might participate in another tumour development as well by controlling the NOTCH-mTOR signalling pathway. And hence, STYX being involved in numerous cancers, its part in modifying the NOTCH-mTOR interaction via FBXW7 permits further than consideration [63]. 

FBXW7 is a substrate differentiation factor of an E3 ubiquitin ligase of the SKP1-cullin-F-box (SCF) type that is responsible for the ubiquitin-dependent degradation of cyclin E. (encoded by CCNE1). When all uterine serous carcinomas were evaluated together, molecular genetic anomalies in the cyclin E pathway caused by FBXW7 point mutations, FBXW7 deletions, or CCNE1 ampli cation were found in more than half of them. Stimulation of cyclin E, whether by preventing its ubiquitin-dependent protein degradation owing to FBXW7 mutations or by elevating its expression due to gene ampli cation, may play a key role in uterine serous carcinoma carcinogenesis. SNP array analysis and immunohistochemistry based CCNE1 expression variation analysis also ensure the same functionality [64]. Zhao et al., discovered that FBW7 phosphorylates GSK3 and recruits KLF5 for ubiquitinmediated proteasomal destruction [65]. Aberrant expression of FBW7 diminishes the KLF5 protein level and its half-life, while deactivation of FBW7 surges the KLF5 protein and half-life [66]. These two groups' ndings support the idea that FBW7 is a critical negative regulator regulating KLF5-mediated cell proliferation. Mutations in FBXW7 increase KLF5 expression. FBXW7 variants impact on chemoresistance: FBXW7's antitumor effects are mostly achieved through controlling the network of proteins degradation, many of the members of proteins such as cyclin E, c-Myc, and Notch have oncogenic functions, Mutated FBXW7 is also known to induce oncoprotein stabilisation in tumours, resulting in chemoresistance induction. As a result, FBXW7 protein downregulation may contribute to tumour development and chemoresistance. As a result, FBXW7 has been recommended as a possible therapeutic target for improving chemotherapeutic drug sensitivity and e cacy [67]. The FBXW7 mutation, which primes the dysfunctional FBXW7 by producing missense mutations in three arginine residues (R465, R479, and R505), could be the basis for the accumulation of a wide range of substrates, which could be essential in chemoresistance [68]. Richter et al identi ed FBXW7 as a new FBXO45 substrate and investigated its function in cancerous cells [69]. In another study, researchers found that blocking FBXO45arbitrated FBXW7 depletion could help with drug resistance in chemotherapeutic treatment by increasing mitotic cell death. In other research, some mutations may affect the degradation of FBXW7 targets differently than the hot area arginine mutations (R465, R479, and R505). Design of small inhibitors that target speci c downstream signalling pathways and/or affect FBXW7 substrate preference could be aided by a better understanding of the conformational changes that generate these symptoms [70]. Earlier research has investigated the role of Fbw7 in cancer chemoresistance in a variety of cancers [71, 72]. c-Myc, nuclear factor erythroid 2-related factor 2, myeloid leukaemia cell differentiation protein Mcl-1 (Mcl-1), and transcription factor SOX-9 are all participating in chemoresistance in cancers such pancreatic cancer, gastric cancer, and colorectal cancer [73, 74]. According to Tong J et al, FBXW7 mutations in colorectal cancer cells impede Mcl-1 degradation, boosting the development of resistance to regorafenib-based targeted therapy [75]. FBXW7 ablation in ovarian cancer cells inhibited c-Myc degradation, which was like the ndings in colon cancer cell lines. This renders the cells more resistant to vincristine-induced cell death. On the one hand, the above-mentioned research studies underlined the crucial role of FBXW7 in chemotherapeutic drug therapeutic effects, while on the other hand, they provided much-needed information for developing viable techniques to increase cancer cell sensitivity to vincristine [76]. Standard chemotherapy was shown to be more resistant in FBXW7-de cient leukaemia-initiating cells (LICs), but imatinib was found to be more sensitive [77]. Combining FBXW7 genetic ablation and imatinib is more effective than any of these approaches alone in cancer animal models, according to studies. When all these aspects are considered, it becomes evident that FBXW7 plays an important role. 

Out of fty-eight nsSNP's reported within the WD40 domain of FBXW7, ten were related to gynaecological cancer and had clinical signi cance; the remaining sixty deleterious nsSNPs were assessed for their mutational impact on FBXW7 and tabulated in the supplementary le 1. Our comprehensive study assessed all identi ed deleterious nsSNPs localized in the WD40 domain decreased stability of the FBXW7 structure. Only three of the ve nsSNPs within the F-box domain have been shown to have a negative impact on the FBXW7 structure. The signi cance of arginine substitution among malignancies was revealed by proteins with the highest ratio of arginine substitution events in the CCLE database. Arginine has highly unusual properties studies showed that arginine is most frequently lost in mutations in cancer. Out of forty-three arginine residues twenty-six substitutions reported in FBXW7. TP53 and PTEN are the other proteins with arginine substitutions. In our studies we found twelve nsSNP's as deleterious out of eighteen arginine substitutions within the domain region of FBXW7. Increasing evidence about the FBXW7 variant's role in cancer induction and chemoresistance emphasizes the need for this kind of comprehensive study, which would be helpful in re ning the currently available therapeutic regimen for gynaecological cancer.
section_name: Structural effect of point mutation on human FBXW7 protein

section_content: FBXW7 is known for its ubiquitylation and proteasome degradation function towards its oncoprotein targets, namely cyclin E, c-JUN, c-MYC, NOTCH-1, and MCL-1. A knockout study revealed that nearly ninety proteins were targeted as substrates by FBXW7. Many of these substrates are transcription factors or important signalling molecules that control a variety of cellular processes, resulting in tumour growth and development. Mutations in FBXW7 frequently occur in various human cancers and are reported to have a chemoresistance association also. 

The current intracellular study of all functional FBXW7 mutants and reported nsSNPs with deleterious effects sheds light on the structural level impact on the FBXW7 structure. Positively charged basic residues, such as arginine, are typically seen ionised at neutral pH on protein surfaces in these residues, electrostatic contact or surface charge-charge interaction is thought to contribute to protein. stability. In addition to hydrogen bonds, electrostatic phenomena such as salt bridges play an important role in protein stability. A salt bridge or ion pair is formed when oppositely charged residues such as Arg, Glu, Asp, His, and Lys contact. As a result, substituting other amino acids for arginine has an impact on the development of salt bridges with neighbouring amino acids. This is the rst comprehensive in silico investigation of all functional nsSNPs found in both FBXW7 domains. Our ndings in this current study will provide a guide to the role of FBXW7 variants' role in diagnostic and therapeutic interventions.
section_name: Conclusion

section_content: Ethical Approval This article does not contain any studies with human participants or animals performed by any of the authors. Hence, no formal consent is required. 

Consent to Participate All the authors have given the consent to participate in the present research concept. 

Consent to Publish All authors have read the nal manuscript and gave the consent for publishing the manuscript. 

Authors Contributions JCH has reviewed and compiled the paper and conceived and designed the protocol. AVK helped in understanding the bioinformatic tools incorporated in the paper. AVK helped in understanding the mechanism of FBXW7 mutants which helped in the compilation of the manuscript. JCH helped in reviewing the relevant papers and compilation of paper.
section_name: Declarations

section_content: Competing Interests The authors declare that they have no con icts of interest. 

Availability of data and materials The authors declare that the data and materials are transparent.
section_name: Funding No funding received for the present work

section_name: Supplementary Files

section_content: This is a list of supplementary les associated with this preprint. Click to download. 

Supplementarytable1. docx
section_name: Supplementary Files